ArticleFrontiers in immunology2022

Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy.

Roberta Liberato Pagni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.